Loss-of-function of the glucose-6-phosphate transporter is caused by biallelic mutations in SLC37A4 and leads to glycogen storage disease Ib. Here we describe a second disease caused by a single dominant mutation in the same gene. The mutation abolishes the ER retention signal of the transporter and generates a weak Golgi retention signal. Intracellular mislocalization of the transporter leads to a congenital disorder of glycosylation instead of glycogen storage disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451446 | PMC |
| http://dx.doi.org/10.1016/j.ymgmr.2020.100636 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Biochemical characterization of the human ubiquitous glucose-6-phosphatase in neutrophil granulocytes.
FEBS Open Bio
November 2024
Department of Molecular Biology, Institute of Biochemistry and Molecular Biology, Semmelweis University, Budapest, Hungary.
Glucose-6-phosphatase-β (G6PC3) is a ubiquitous phosphatase present in the endoplasmic reticulum, which, unlike G6PC1, is not responsible for maintaining blood glucose level under starvation. Recently, G6PC3 has been shown to play an important role in neutrophil granulocytes, eliminating the toxic metabolite 1,5-anhydroglucitol-6-phosphate. The present study aimed to look for alternative substrates for the enzyme and outline the expression changes in the parts of this multicomponent system during neutrophil granulocyte differentiation.
View Article and Find Full Text PDFPrecision-cut liver slices as an ex vivo model to assess impaired hepatic glucose production.
Commun Biol
November 2024
Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Fasting hypoglycemia is a severe and incompletely understood symptom of various inborn errors of metabolism (IEM). Precision-cut liver slices (PCLS) represent a promising model for studying glucose production ex vivo. This study quantified the net glucose production of human and murine PCLS in the presence of different gluconeogenic precursors.
View Article and Find Full Text PDFAccumulation of dually targeted StGPT1 in chloroplasts mediated by StRFP1, an E3 ubiquitin ligase, enhances plant immunity.
Hortic Res
November 2024
National Key Laboratory for Germplasm Innovation & Utilization of Horticultural Crops, Huazhong Agricultural University (HZAU), Wuhan 430070, China.
Article Synopsis
- - Chloroplasts are vital for photosynthesis and making various metabolites, and they also influence plant immunity by producing phytohormones like SA and JA.
- - The potato E3 ligase StRFP1 enhances late blight resistance, and it interacts with the glucose 6-phosphate transporter StGPT1, which is located in both chloroplasts and the endoplasmic reticulum (ER).
- - StRFP1 ubiquitinates StGPT1 at the ER, suggesting a new way that plant E3 ligases help improve immunity by managing protein levels and location in plant cells.
Aberrant glucose metabolism underlies impaired macrophage differentiation in glycogen storage disease type Ib.
FASEB J
November 2023
Department of Biotechnology and Bioinformatics, College of Science and Technology, Korea University, Sejong, Republic of Korea.
Glycogen storage disease type Ib (GSD-Ib) is an autosomal recessive disorder caused by a deficiency in the glucose-6-phosphate (G6P) transporter (G6PT) that is responsible for transporting G6P into the endoplasmic reticulum. GSD-Ib is characterized by disturbances in glucose homeostasis, neutropenia, and neutrophil dysfunction. Although some studies have explored neutrophils abnormalities in GSD-Ib, investigations regarding monocytes/macrophages remain limited so far.
View Article and Find Full Text PDFSGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia.
Cell Mol Life Sci
August 2023
Metabolic Research Group, de Duve Institute and UCLouvain, de Duve Institute, 75, Av. Hippocrate, 1200, Brussels, Belgium.
Neutropenia and neutrophil dysfunction in glycogen storage disease type 1b (GSD1b) and severe congenital neutropenia type 4 (SCN4), associated with deficiencies of the glucose-6-phosphate transporter (G6PT/SLC37A4) and the phosphatase G6PC3, respectively, are the result of the accumulation of 1,5-anhydroglucitol-6-phosphate in neutrophils. This is an inhibitor of hexokinase made from 1,5-anhydroglucitol (1,5-AG), an abundant polyol in blood. 1,5-AG is presumed to be reabsorbed in the kidney by a sodium-dependent-transporter of uncertain identity, possibly SGLT4/SLC5A9 or SGLT5/SLC5A10.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!